Recent trials have provided preliminary evidence suggesting that BRCA1 methylation may be associated with a more favorable response to chemotherapy, as well as polyadenosine diphosphate-ribose polymerase inhibition, in breast cancer.8,32 Neither trial distinguished somatic from constitutional methylation. This evidence concerns the gene BRCA1 and breast carcinoma.